申请人:HISAMITSU PHARMACEUTICAL CO. INC.
公开号:EP0846473A1
公开(公告)日:1998-06-10
It is an object of this invention to provide a plaster structure for iontophoresis in which a predetermined amount of physiologically active agents initially set can be stably kept or held without any loss until it is applied to a patient, and when the agents are applied to the patient, the predetermined amount of physiologically active agents initially set can be applied stably and continuously to an entire body of the patient and concurrently a mutual action between the physiologically active agents or additive agents and the adhesive agent is prevented, an adhering power of the adhesive agent is kept and it may not be peeled off during its application.
The plaster structure for iontophoresis is comprised of an electrical conductive medicinal substance storing layer 1 containing the physiologically active agents, a backing layer 2 covering the medicinal substance storing layer 1 and having an electrode 3 installed therein, a protection layer 4 supporting the medicinal substance storing layer 1 and which is non-permeable against the physiologically active agents, an adhesive agent layer 5 comprised of pressure-sensitive adhesive agent with a superior skin adhering characteristic and/or mucous membrane adhering characteristic laminated on the other surface of the protection layer 4, a liner layer 6 laminated on the other surface of the adhesive agent layer 5, and a notch part 7 formed in the protection layer 4.
本发明的目的是提供一种用于离子透入疗法的膏药结构,在这种结构中,最初设定的预定量的生理活性剂可以稳定地保存或保持,直到涂抹到患者身上,并且当这些生理活性剂涂抹到患者身上时不会有任何损失、可将最初设定的预定量生理活性剂稳定、连续地涂抹到患者全身,同时可防止生理活性剂或添加剂与粘合剂之间的相互影响,保持粘合剂的粘附力,并且在涂抹过程中不会剥落。
用于离子透入疗法的膏药结构由以下部分组成:含有生理活性剂的导电药剂储存层 1;覆盖药剂储存层 1 并在其中安装电极 3 的背衬层 2;支撑药剂储存层 1 且不渗透生理活性剂的保护层 4、粘合剂层 5,由具有良好的皮肤粘合特性和/或粘膜粘合特性的压敏粘合剂组成,层压在保护层 4 的另一个表面上;衬垫层 6,层压在粘合剂层 5 的另一个表面上;以及在保护层 4 上形成的凹槽部分 7。